Joshua Weitz

Joshua Weitz, MD, currently serves as the Chief Executive Officer of Dermatology Associates of Rochester since July 2014 and as the Chief Medical Officer and a Founding Member of the Clinical Advisory Board at Removery since August 2021. Previously, Joshua Weitz founded Tat Erase, dedicated to laser tattoo removal, which was acquired by Removery in December 2021. Earlier experience includes serving as a physician fellow in Allergy/Immunology and Rheumatology at the University of Rochester Medical Center from 2011 to 2014 and completing Internal Medicine training at the University at Buffalo from 2008 to 2011. Educational background includes a Doctor of Medicine (MD) from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and a Bachelor of Arts (BA) in Chemistry from Colby College.